Last reviewed · How we verify
NCT03031769: SPACE
Symptoms and Physical Activity in COPD Patients in Europe
trial in COPD in 2,176 participants. Completed in 31 August 2017.
31 August 2017
Quick facts
| Lead sponsor | AstraZeneca |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,176 |
| Start date | 21 December 2016 |
| Primary completion | 31 August 2017 |
| Estimated completion | 31 August 2017 |
| Sites | 1 location across Romania |
Conditions studied
- COPD — all drugs for COPD →
Sponsor
AstraZeneca — full company profile →
Who can join
Adults 40 to 130, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An observational, multinational, cross sectional study to describe 24-hs symptoms, physical activity and their relationship in stable COPD patients in Europe
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
Mihaltan F, Adir Y, Antczak A, Porpodis K, et al · · 2019 · cited 15× · PMID 31088560 · DOI 10.1186/s12931-019-1053-7 -
Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
Hareendran A, Make BJ, Zaiser E, Garcia Gil E. · · 2018 · cited 11× · PMID 29849455 · DOI 10.2147/copd.s152087 -
High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study.
Mihaltan F, Rajnoveanu RM, Arghir OC, Alecu S, et al · · 2021 · cited 5× · PMID 34522093 · DOI 10.2147/copd.s321197 -
Correlation of symptoms and physical activity level in chronic obstructive pulmonary disease patients: results from the observational SPACE study.
De Bontridder S, Corhay JL, Haenebalcke C, Fievet F, et al · · 2022 · cited 2× · PMID 34252000 · DOI 10.1080/17843286.2021.1950419
Verify or expand the search:
- PubMed search for NCT03031769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COPD
Currently open trials in the same condition.
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
Other AstraZeneca trials
Trials by the same sponsor.
- NCT06998095 — Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea · not yet recruiting
- NCT07431775 — Saphnelo Use in Females of Child-bearing Potential · not yet recruiting
- NCT07516184 — Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis · NA · not yet recruiting
- NCT07279935 — Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resec · Phase 4 · not yet recruiting
- NCT07279948 — A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilian Cohort o · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03031769 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AstraZeneca
- Last refreshed: 2 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03031769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing